Skip to main content
. 2009 May;135(5):1293–1300. doi: 10.1378/chest.08-1160

Figure 3.

Figure 3

Association between serum VEGF-D levels in patients with LAM and initial Dlco percent predicted. Top, A: univariate analysis of correlation between the serum VEGF-D levels in 111 patients with LAM and the initial Dlco percent predicted. Center, B, and bottom, C: for multivariate analysis, LAM patients were grouped by lymphatic involvement. Serum VEGF-D levels correlated with initial Dlco percent predicted for patients with lymphatic involvement. (+) lymphatics = patients with lymphangioleimyomas and/or adenopathy; (-) lymphatics = patients without lymphangioleiomyomas or adenopathy; ♦ = serum measurement of VEGF-D from one patient with LAM.